Audiovisual distraction in nasal upper gastrointestinal endoscopy.
- Conditions
- chronic refractory gastroesophagical refluxOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
- Registration Number
- ACTRN12619001751167
- Lead Sponsor
- Hospital Universitario, Dr. José E. González, Universidad Autónoma de Nuevo León
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 54
Patients with the following criteria will be included in the study:
Male or female, 18-65 years of age,
Globus,
Symptomatology of chronic refractory reflux to pharmacological therapy,
Dyspeptic syndrome without alarm data,
Non-cardiac chest pain.
Patients with the following criteria will be excluded from the study:
Dysphagia,
Alarm signs (weight loss, etc.),
History of food impact,
Previous use of aspirin or anticoagulants (3 months),
History of recurrent epistaxis,
History of nasal trauma,
Chronic sinusitis,
Previous nasal surgeries,
Highly anxious patients.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the anxiety score, measured by Beck Anxiety Scale in the interventional vs control group during the nasal endoscopy procedure.[30 minutes post nasal endoscopy procedure.];To compare the anxiety score, measured by Patient Health Questionnaire (PCSQ-9), in the interventional vs control group during the nasal endoscopy procedure.[30 minutes post nasal endoscopy procedure.]
- Secondary Outcome Measures
Name Time Method To compare the number of successful completed nasal endoscopy procedures assessed by localization and reaching the esophagus, stomach and duodenal portions of the gastrointestinal tract during the nasal endoscopy, in the interventional vs control group 30 minutes post nasal endoscopy procedure.[30 minutes post nasal endoscopy procedure.]